Company name: MediTox s.r.o.
Preclinical/toxicological assessment of pharmaceuticals, biological substances, medical devices, food additives and chemical substances according to EMA/ICH, US FDA, OECD, ISO 10993, development of animal models of selected human diseases, contract research
Preclinical research and development in the field of cardiovascular disorders (specialized hemodynamic laboratory, experimental myocardial infarction, reperfusion liver damage), efficiency and safety of vaccines (ferret, hamster models), neurology (chronic traumatic damage of spinal cord in pigs), diabetes (type I diabetes in rodents, type II diabetes in non-human primates), eye diseases (model of chronic glaucoma in dogs), arthritis. Complex preclinical/toxicological assessment of pharmaceuticals (including biological ones), medical devices and food additives according to EMA/ICH, US FDA, OECD, ISO 10993 and according to good laboratory practice, contract research and development of animal models of selected human diseases. An important advantage is experience with genetically modified organisms, high professional standard, strict adherence to scientific and business ethics, high credibility, reliability and wide international activity.+Field Affiliation